Analysing recent socioeconomic trends in coronary heart disease mortality in England, 2000-2007: A population modelling study

PLoS Medicine

Volumn 9, Issue 6, 2012, Pages 12-

  Bajekal, Madhavi ^a   Scholes, Shaun ^a   Love, Hande ^b   Hawkins, Nathaniel ^c   O'Flaherty, Martin ^d   Raine, Rosalind ^a   Capewell, Simon ^d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b Pensions and Annuity Group   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; BLOOD CLOT LYSIS; BODY MASS; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; HEART DEATH; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORTALITY; NONBIOLOGICAL MODEL; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; RESUSCITATION; RISK FACTOR; SMOKING; SOCIOECONOMICS; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; ADULT; BIOLOGICAL MODEL; CORONARY ARTERY DISEASE; FEMALE; MALE; POPULATION DYNAMICS; PREVALENCE;

ADULT; CORONARY DISEASE; ENGLAND; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; POPULATION DYNAMICS; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS;

EID: 84864718416     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1001237     Document Type: Article

References (40)

1. Bajekal M, Scholes S, O'Flaherty M, Raine R, Norman P, et al. (2010) Trends in CHD mortality by socioeconomic circumstances, England 1982-2006. J Epidemiol Community Health 64 (Suppl 1) p.A2.
2. The Marmot Review (2010) Fair society, healthy lives: strategic review of health inequalities in England post-2010. London: The Marmot Review, Available: http://www.instituteofhealthequity.org/projects/fair-society-healthy-lives-the-marmot-review.
3. Leyland AH, (2004) Increasing inequalities in premature mortality in Great Britain. J Epidemiol Community Health 58: 296-302.
4. Unal B, Critchley JA, Capewell S, (2004) Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 109: 1101-1107.
5. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, et al. (2007) Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med 356: 2388-2398 Detailed technical appendix of model available available:http://www.nejm.org/doi/suppl/10.1056/NEJMsa053935/suppl_file/nejm_ford_2388sa1.pdf.
6. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, et al. (2010) Association of temporal trends in risk factors and treatment uptake with coronary heart disease mortality, 1994-2005. JAMA 303: 1841-1847.
7. Department of Health (2000) National service framework for coronary heart disease Crown Copyright, London Department of Health.
8. The NHS Information Centre for Health and Social Care (2004) Quality and outcomes framework: Introduction to QOF. Available: http://www.ic.nhs.uk/statistics-and-data-collections/supporting-information/audits-and-performance/the-quality-and-outcomes-framework/qof-information/introduction-to-qof. Accessed 8 May 2012.
9. UK Food Standards Agency (2006) New salt reduction targets published as part of FSA campaign to reduce salt in our diets. Available: http://webarchive.nationalarchives.gov.uk/20120206100416/http://food.gov.uk/news/pressreleases/2006/mar/targets. Accessed 8 May 2012.
10. UK Food Standards Agency (2007) FSA Board recommends voluntary approach to trans fats in food. Available: http://webarchive.nationalarchives.gov.uk/20120206100416/http://food.gov.uk/news/newsarchive/2007/dec/trans. Accessed 8 May 2012.
11. House of Commons Committee of Public Accounts (2010) Tackling inequalities in life expectancy in areas with the worst health and deprivation. House of Commons London: The Stationery Office Limited. Available: http://www.publications.parliament.uk/pa/cm201011/cmselect/cmpubacc/470/470.pdf. Accessed 8 May 2012.
12. Capewell S, Graham H, (2010) Will cardiovascular disease prevention widen health inequalities? PLoS Med 7: e10000320 doi:10.1371/journal.pmed.1000320.
13. Department for Communities and Local Government (2007) The English indices of deprivation 2007. Available www.communities.gov.uk/publications/communities/indicesdeprivation07. Accessed 8 May 2012.
14. Mant J, Hicks N, (1995) Detecting differences in quality of care- the sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 311: 793-796.
15. Kuulasmaa K, Tunstall-Pedoe H, Dobson A, Fortmann S, Sans S, et al. (2000) Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations. Lancet 355: 675-687.
16. Barendregt JJ, (2010) The effect size in uncertainty analysis. Value in Health 13: 388-391.
17. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K, (2006) Pattern of declining blood pressure across replicate population surveys of the WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ 332: 629-632.
18. UK Food Standards Agency (2008) An assessment of dietary sodium levels among adults (aged 19-64) in the UK general population in 2008, based on analysis of dietary sodium in 24 hour urine samples. London: National Centre for Social Research. Available: http://www.food.gov.uk/multimedia/pdfs/08sodiumreport.pdf. Accessed 8 May 2012.
19. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, et al. (2011) National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants. Lancet 377: 568-577.
20. Bauld L, Judge K, Platt S, (2007) Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control 16: 400-404.
21. National Institute of Health and Clinical Excellence (2010) Prevention of cardiovascular disease at population level. Available: http://guidance.nice.org.uk/PH25/. Accessed 8 May 2012.
22. Foresight (2007) Tackling obesities: future choices. UK Government Office of Science. Available: http://www.bis.gov.uk/foresight/our-work/projects/published-projects/tackling-obesities/reports-and-publications.
23. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, et al. (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364: 937-952.
24. Kivimäki M, Shipley MJ, Ferrie JE, Singh-Manoux A, Batty GD, et al. (2008) Best-practice interventions to reduce socioeconomic inequalities of coronary heart disease mortality in UK: a prospective occupational cohort study. Lancet 372: 1648-1654.
25. Kivimäki M, Lawlor DA, Davey Smith G, Kouvonen A, Virtanen M, et al. (2007) Socioeconomic position, co-occurrence of behavior-related risk factors, and coronary heart disease: the Finnish Public Sector study. Am J Public Health 97: 874-879.
26. Harald K, Koskinen S, Jousilahti P, Torppa J, Vartiainen E, et al. (2008) Changes in traditional risk factors no longer explain time trends in cardiovascular mortality and its socioeconomic differences. J Epidemiol Community Health 62: 251-257.
27. National Co-ordinating Centre for NHS Service Delivery and Organisation R&D (2005) Concordance, adherence and compliance in medicine taking. Available: http://www.medslearning.leeds.ac.uk/pages/documents/useful_docs/76-final-report%5B1%5D.pdf. Accessed 8 May 2012.
28. Ockene J, Ma Y, Zapka J, Pbert L, Valentine Goins K, et al. (2002) Spontaneous cessation of smoking and alcohol use among low-income pregnant women. Am J Prev Med 23: 150-159.
29. Schüz B, Marx C, Wurm S, Warner LM, Ziegelmann JP, et al. (2011) Medication beliefs predict medication adherence in older adults with multiple illnesses J Psychosom Res 70: 179-187.
30. Capewell S, Morrison CE, McMurray JJ, (1999) Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 81: 380-386.
31. Capewell S, Beaglehole R, Seddon M, McMurray J, (2000) Explanation for the decline in coronary heart disease mortality rates in Auckland, New Zealand, between 1982 and 1993. Circulation 102: 1511-1516.
32. Palmieri L, Bennett K, Giampaoli S, Capewell S, (2010) Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 100: 684-692.
33. Aspelund T, Gudnason V, Magnusdottir BT, Andersen K, Sigurdsson G, et al. (2010) Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PloS One 5: e13957 doi:10.1371/journal.pone.0013957.
34. Leyland AH, (2005) Socioeconomic gradients in the prevalence of cardiovascular disease in Scotland: the roles of composition and context. J Epidemiol Community Health 59: 799-803.
35. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, et al. (2005) Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162: 764-773.
36. Davey Smith G, Hart C, Watt G, Hole D, Hawthorne V, (1998) Individual social class, area-based deprivation,cardiovascular disease risk factors, and mortality: the Renfrew and Paisley study. J Epidemiol Community Health 52: 399-405.
37. Doran T, Kontopantelis E, Valderas JM, Campbell S, Roland M, et al. (2011) Effect of financial incentives on incentivised and non-incentivised clinical activities: longitudinal analysis of data from the UK Quality and Outcomes Framework. BMJ 342: d3590 doi:10.1136/bmj.d3590.
38. Zatonski WA, Willett W, (2005) Changes in dietary fat and declining coronary heart disease in Poland: population based study. BMJ 331: 187-188.
39. Cobiac LJ, Vos T, Veerman JL, (2010) Cost-effectiveness of interventions to reduce dietary salt intake. Heart 96: 1920-1925.
40. Glantz S, Gonzalez M, (2012) Effective tobacco control is key to rapid progress in reduction of non-communicable diseases. Lancet 379: 1269-1271.